Your browser doesn't support javascript.
loading
Long-term treatment burden following allogeneic blood and marrow transplantation in NSW, Australia: a cross-sectional survey.
McErlean, Gemma; Brice, Lisa; Gilroy, Nicole; Kabir, Masura; Greenwood, Matt; Larsen, Stephen R; Moore, John; Gottlieb, David; Hertzberg, Mark; Brown, Louisa; Hogg, Megan; Huang, Gillian; Ward, Christopher; Kerridge, Ian.
Afiliación
  • McErlean G; School of Nursing, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW, Australia. gmcerlean@uow.edu.au.
  • Brice L; Cancer Services, South Western Sydney Local Health District, Sydney, NSW, Australia. gmcerlean@uow.edu.au.
  • Gilroy N; Centre for Applied Nursing Research and Ingham Institute of Applied Medical Research, Sydney, NSW, Australia. gmcerlean@uow.edu.au.
  • Kabir M; Blood and Marrow Transplant Network, New South Wales Agency for Clinical Innovation, Sydney, NSW, Australia. gmcerlean@uow.edu.au.
  • Greenwood M; Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Larsen SR; Blood and Marrow Transplant Network, New South Wales Agency for Clinical Innovation, Sydney, NSW, Australia.
  • Moore J; Centre for Infectious Diseases and Microbiology, Westmead Hospital, Sydney, NSW, Australia.
  • Gottlieb D; Westmead Breast Cancer Institute, Sydney, NSW, Australia.
  • Hertzberg M; Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Brown L; Northern Blood Research Centre, Kolling Institute, University of Sydney, Sydney, NSW, Australia.
  • Hogg M; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Huang G; Department of Haematology, St Vincents Hospital, Sydney, NSW, Australia.
  • Ward C; Department of Haematology, Westmead Hospital, Sydney, NSW, Australia.
  • Kerridge I; Faculty of Medicine and Health Sciences, University of Sydney, Sydney, NSW, Australia.
J Cancer Surviv ; 16(2): 432-444, 2022 04.
Article en En | MEDLINE | ID: mdl-33813667

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médula Ósea / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Oceania Idioma: En Revista: J Cancer Surviv Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médula Ósea / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Oceania Idioma: En Revista: J Cancer Surviv Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos